Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A prospective study of cancer survivor patients enrolling in a pilot aerobic exercise program. The total enrollment will be fifteen patients. The study timeline includes a screening period of 4 weeks, baseline period of 2 weeks, and active study intervention for 12 weeks. Study enrollment will continue until all 15 subjects are enrolled or up to 12 months, whichever comes first.
Study Population: Adult cancer survivors within one year of completing cancer-directed therapy.
Study Objective: To determine the feasibility of a prescription exercise program in a cancer survivor population
Specific Objectives:
Study Endpoints/Outcomes:
A. Percentage of participants who complete the Program. B. Change in systolic blood pressure C. Change in BMI D. Change in body composition E. Change in Average daily step count F. Change in predicted VO2 max F. Change in participant-reported wellness surveys (SEE, SRQ, and Sleep Surveys) G. Change in Circumference measurements (hip, waist, and neck) H. Improvement in laboratory parameters (Hgb A1c, CRP, Lipid profile, IL-6, Alipoprotein B, Vitamin D-25-OH, Vitamin B12, Folate) I. Cancer recurrence
Sample Size: Fifteen subjects
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aerobic Exercise | Other | Participants will engage in aerobic exercise at HNH fitness at a minimum of 2 days a week for 12 weeks. Participants will have their daily step count collected via the Fitbit during this period. VO2 measurements will also be collected during active intervention using the UNCCRI protocol. The structured aerobic exercise program (Weeks 3-14) will entail 30 minutes of aerobic activity, 3 days a week, on the treadmill, at a goal of between 50 to 70% of predicted VO2 maximum heart rate. All structured aerobic program sessions will take place at Holy Name Health (HNH) Fitness and will be overseen by our collaborator and Director of Human Performance (Reg Grant). Exercise data will be recorded in the Technogym MyWellness cloud. Participants who drop out or discontinue attendance (defined as 4 consecutive sessions missed without notification of absence) before completion of the 12-week study intervention period will be replaced. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of providing a structured in-person aerobic exercise intervention | To determine the feasibility of providing a structured in-person aerobic exercise training intervention to cancer survivor patients by determining the percentage of enrolled patients who complete the study. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Weight in Lbs | Change in weight (Lbs) from baseline | 6 months |
| Blood Pressure in mmHg | Change in blood pressure (mmHg) from baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| George Miller, MD | Contact | 2015307934 | Gemiller@holyname.org | |
| Dan Rector, RN | Contact | 2018334742 | 4742 | drector@holyname.org |
| Name | Affiliation | Role |
|---|---|---|
| George Miller, MD | Holy Name Medical Center | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Heart Rate in bpm | Change in Heart rate (bpm) from baseline | 6 months |
| Body Mass Index (BMI) in Kg/m2 | Change in BMI from baseline. BMI will be calculated as weight (kg)/height (m2). | 6 months |
| Predicted VO2 max in ml/kg/min | Change in predicted VO2 max from baseline calculated as the milliliters of Oxygen used per kg of body weight per minute | 6 months |
| Percentage lean body mass | Change in lean body mass percentage from baseline | 6 months |
| Percentage visceral fat | Change in visceral fat percentage from baseline | 6 months |
| Percentage total body fat | Change in total body fat percentage from baseline | 6 months |
| Hip circumference measurement in cm | Change in hip circumference measurements from baseline | 6 months |
| Waist circumference measurement in cm | Change in waist circumference measurements from baseline | 6 months |
| Neck circumference measurements in cm | Change in Neck circumference measurements from baseline | 6 months |
| Laboratory Assessments of Nutrition, Glucose control and cardiovascular health | Change in laboratory Assessments of Nutrition, Glucose control and cardiovascular health | 6 months |
| Average daily step count | Change in average daily step count from baseline | 6 months |